Skip to main content
OpenTrials

Clinical trial condition

Hemoglobinuria, Paroxysmal

Explore clinical trials studying Hemoglobinuria, Paroxysmal. Study availability and eligibility vary by location and protocol.

166 public trials 28 recruiting studies
Refine in advanced search Browse all conditions

Hemoglobinuria, Paroxysmal trial results

Active, not recruiting

Real-life Treatment Outcomes of Ravulizumab in PNH

NCT06633536

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • Research Site Bialystok, Poland
  • Research Site Brzozów, Poland
  • Research Site Bydgoszcz, Poland
  • Research Site Gdansk, Poland
View Trial Details
Active, not recruiting

Specified Drug-use Surveillance of Fabhalta Capsules

NCT06606314

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • Novartis Investigative Site Hachinohe, Aomori, Japan
  • Novartis Investigative Site Chiba, Japan
  • Novartis Investigative Site Aizu-Wakamatsu, Fukushima, Japan
  • Novartis Investigative Site Sapporo, Hokkaido, Japan
View all 91 locations
View Trial Details
Active, not recruiting

A Real World Effectiveness Study of Pegcetacoplan in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)

NCT05776472

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • Liverpool Hospital Liverpool, New South Wales, Australia
  • Calvary Mater Newcastle Waratah, New South Wales, Australia
  • Sunshine Coast University Hospital Birtinya, Queensland, Australia
  • Canberra Hospital Garran, Australia
View all 87 locations
View Trial Details
Active, not recruiting

A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Not Previously Treated With Complement Inhibition

NCT04654468

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • West China Hospital, Sichuan University Chengdu, China
  • Guangdong General Hospital Guangzhou, China
  • Institute of Hematology and Hospital of Blood Disease Tianjin, China
  • Tianjin Medical University General Hospital Tianjin, China
View Trial Details
Active, not recruiting

A Study Evaluating the Efficacy and Safety of Crovalimab Versus Eculizumab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Not Previously Treated With Complement Inhibitors

NCT04434092

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • Organizacion Medica de Investigacion (OMI) Ciudad Autonoma Buenos Aires, Argentina
  • *X*CEPHO - Centro de Estudos e Pesquisas em Hematologia e Oncologia Santo André, São Paulo, Brazil
  • Beneficencia Portuguesa de Sao Paulo São Paulo, Brazil
  • Peking Union Medical College Hospital Beijing, China
View all 63 locations
View Trial Details

Related conditions